Revenue Growth - The company reported a significant increase in revenue, with a year-over-year growth of 15% for the third quarter of 2024, reaching 500million[17].−Thecompanyanticipatesarevenuegrowthof10550 million and 560million[17].−TotalrevenuesforthethreemonthsendedSeptember30,2024,were206.8 million, an increase of 8.8% compared to 191.2millionforthesameperiodin2023[21].−TotalrevenuesfortheninemonthsendedSeptember30,2024,were606.5 million, a 6.3% increase from 570.5millionforthesameperiodin2023[156].−Thecompanyreportedarevenueof149.5 million for point-in-time recognition for the three months ended September 30, 2024, compared to 128.0millioninthesameperiodof2023,markinga16.710.2 million for the three months ended September 30, 2024, compared to 7.9millioninthesameperiodlastyear,indicatingafocusoninnovation[21].FinancialPerformance−GrossprofitforthethreemonthsendedSeptember30,2024,was92.9 million, up from 80.8millioninthesameperiodlastyear,reflectingagrossmarginimprovement[21].−Thecompanyreportedagrossprofitmarginof44.913.6 million, compared to a net loss of 12.1millionforthesameperiodin2023[21].−OperatingexpensesforthethreemonthsendedSeptember30,2024,totaled94.5 million, slightly higher than 91.9millionintheprioryear[21].−Thecompanyexperiencedaforeigncurrencytranslationgainof29.5 million for the three months ended September 30, 2024, compared to a loss of 20.3millioninthesameperiodlastyear[23].AcquisitionsandIntegration−Thecompanyhassuccessfullyintegratedtworecentacquisitions,whichareprojectedtoenhanceoperationalefficiencyby1531.4 million, including 14.5millioninintangibleassetsand17.4 million in goodwill[70]. - The Company recorded a 1.4millionnetincreaseingoodwillrelatedtotheecacquisitionduringtheninemonthsendedSeptember30,2024[70].DebtandFinancing−AsofSeptember30,2024,totalthird−partydebtamountedto696.8 million, slightly increasing to 698.4millionbyDecember31,2023[8].−The2021CreditAgreementincludesan830.0 million senior secured first lien term loan facility and a 90.0millionseniorsecuredrevolvingfacility,withthetermloanmaturingonOctober20,2028[100].−Theinterestrateonthetermloanwas6.85103.4 million as of September 30, 2024, compared to 95.6milliononDecember31,2023,reflectinganincreaseof8.51,543.3 million, with an accumulated deficit of 490.2million[28].−Thebalanceoftotalstockholders′equityasofDecember31,2023,was1,550.0 million, with an accumulated deficit of 505.4million[30].SegmentPerformance−Medicalsegmentrevenuesreached74.1 million in Q3 2024, up from 68.8millioninQ32023,whileTechnologiessegmentrevenuesincreasedto132.7 million from 122.4million[153].−TotalsegmentincomefromoperationsforQ32024was18.7 million, compared to 9.4millioninQ32023,indicatingasignificantimprovementinoperationalperformance[153].RestructuringandCosts−TotalrestructuringexpensesfortheninemonthsendedSeptember30,2024,amountedto4.7 million, compared to 1.6millionforthesameperiodin2023[189].−TheCompanyincurredseveranceandemployeecostsof1.5 million for the three months ended September 30, 2024, and $0.3 million for the same period in 2023[184].